AMN Healthcare Services, Inc. (AMN) Company Overview

US | Healthcare | Medical - Care Facilities | NYSE

What does AMN Healthcare do?

AMN Healthcare Services, Inc. is a New York Stock Exchange-listed healthcare workforce company trading under the ticker AMN. It began as a travel-nursing business and now coordinates clinicians, physicians, leaders, technology and workforce analytics for healthcare organizations across the United States. Its customers include acute-care hospitals, health systems, clinics, physician groups, schools, home-health providers and other care settings. The company describes its role as bringing together people, processes and technology so clients can maintain patient access while controlling labor complexity.

3
reportable segments in FY2025
13M+
patients reached by AMN professionals in 2025
2,300+
healthcare systems served in 2025
93%
of top U.S. healthcare systems reached in 2025

Which businesses sit inside the company?

Nurse and Allied Solutions
Largest revenue segment
Travel nursing, labor-disruption staffing, local staffing, international nurse placement, allied health and revenue-cycle talent.
Physician and Leadership Solutions
Specialist and executive talent
Locum tenens, interim leadership, executive search and permanent physician placement.
Technology and Workforce Solutions
Higher-margin technology-enabled services
Language interpretation, vendor-management software, workforce optimization, analytics and recruitment-process outsourcing.

The 2025 Form 10-K is the most complete source for the segment definitions, customer profile and competitive landscape. The strategic point is that AMN is no longer merely a recruiter filling isolated vacancies. It increasingly aims to become an operating partner that can forecast demand, source clinicians, manage contingent-labor vendors, credential workers and analyze workforce costs.

Identity item AMN-specific fact Why it matters
Listing NYSE: AMN Public reporting and one-share, one-vote governance make operating results directly visible to institutional shareholders.
Core market U.S. healthcare staffing and workforce solutions Demand is linked to hospital volumes, clinician shortages, wage rates, regulation and health-system budgets.
Key customer concentration Kaiser represented about 22% of FY2025 revenue A large managed-services relationship creates scale but also material renewal and concentration risk.

How does AMN Healthcare make money?

AMN earns most of its revenue by charging healthcare organizations for temporary clinicians, physicians and leaders. The bill rate paid by the client exceeds the compensation, housing, travel, benefits and other direct costs paid for the professional. That spread creates gross profit. Permanent placement, executive search, recruitment-process outsourcing, language services and software-based workforce tools add fee and technology revenue with different margin structures.

1. Client demand
A hospital forecasts vacancies, seasonal needs, a strike, a physician gap or a leadership search.
2. Talent and platform match
AMN recruits, credentials and matches professionals through recruiters, managed programs and digital tools.
3. Assignment delivery
AMN or an approved subcontractor provides labor, logistics, scheduling and compliance support.
4. Revenue and gross profit
The client pays a bill rate or service fee; AMN retains the spread after direct service costs.

Why are managed-services programs strategically important?

Under a managed-services program, AMN can coordinate a client’s broader contingent workforce, including talent supplied by other staffing firms. This embeds AMN in procurement, workflow and data processes and can create switching costs. In FY2025, MSP relationships produced approximately 48% of consolidated revenue; in Q1 2026, the share rose to about 74%, heavily influenced by large labor-disruption activity. MSP scale improves visibility and cross-selling, but large contracts can intensify customer bargaining power.

48%of FY2025 consolidated revenue was generated through MSP relationships, making program depth a central business-model driver.
Revenue stream Pricing logic Primary cost or margin driver
Temporary staffing Hourly or assignment bill rate Clinician pay packages, housing, travel, assignment volume and fill rates
Labor disruption High-volume event pricing and logistics Speed of mobilization, deposits, credentialing capacity and event duration
Permanent placement and search Placement or retained-search fee Search productivity, candidate quality and completion timing
Technology and language services SaaS, transaction, minute-based or managed-service fees Platform utilization, pricing, client retention and service mix

Which segments matter most to revenue and profit?

The annual mix shows a company still dominated by staffing, while profitability is more balanced because Technology and Workforce Solutions carries materially higher gross margins. In FY2025, Nurse and Allied generated $1.647 billion, or about 60.3% of consolidated revenue. Physician and Leadership produced $696.4 million, or 25.5%. Technology and Workforce produced $386.7 million, or 14.2%.

FY2025 revenue mix
Nurse and Allied — $1.647B — 60.3%
Physician and Leadership — $696.4M — 25.5%
Technology and Workforce — $386.7M — 14.2%
Takeaway: staffing supplies the scale, while technology and language services contribute disproportionately to gross profit because of their higher margin.

Where is the margin advantage?

FY2025 gross margins were 23.0% for Nurse and Allied, 27.6% for Physician and Leadership, and 52.7% for Technology and Workforce. Yet the technology segment’s margin fell from 58.9% in FY2024 because of language-service pricing pressure, lower higher-margin VMS revenue and the sale of Smart Square. This distinction matters in valuation: one dollar of technology revenue can create more gross profit than one dollar of staffing revenue, but only if pricing and platform utilization remain resilient.

FY2025 segment gross margins
Technology and Workforce52.7%
Physician and Leadership27.6%
Nurse and Allied23.0%
Bars are indexed to the highest segment margin. Period: FY2025.

What turning points shaped AMN Healthcare’s current strategy?

AMN’s history is best understood as a sequence from travel-nurse specialist to diversified workforce platform. The company’s official history timeline shows how acquisitions and product launches broadened its addressable market and changed its risk profile.

  1. 1985
    American Mobile Nurses was founded, establishing the travel-nursing capability that remains AMN’s volume engine.
  2. 2001
    AMN listed on the NYSE, giving the company public equity and debt-market access for expansion.
  3. 2005
    The MHA Group acquisition added physician staffing and helped create a broader healthcare-talent portfolio.
  4. 2010–2015
    Nursefinders, ShiftWise, Avantas, Onward Healthcare, Locum Leaders and Medefis expanded managed services, analytics, VMS and locum tenens.
  5. 2020
    Stratus Video added language interpretation, increasing technology-enabled and recurring service exposure.
  6. 2023–2024
    MSDR strengthened locum tenens; ShiftWise Flex and WorkWise advanced the technology-centered workforce strategy.
  7. 2025–2026
    AMN sold Smart Square, expanded labor-event technology, partnered with Brightfield and acquired ESSENTIAL leadership-assessment intellectual property.

What does the acquisition record imply?

Acquisitions created breadth, but they also created goodwill and intangible assets that must be supported by future cash flows. The 2023 MSDR transaction cost roughly $291.2 million after the working-capital settlement and added locum-tenens exposure. In FY2025, weaker volumes and margins in Physician and Leadership led to a $109.5 million goodwill impairment, while a revenue-cycle intangible asset generated an additional $18.3 million impairment. The lesson is not that diversification failed; it is that acquired growth must clear a high return threshold after integration, amortization and financing costs.

What did AMN Healthcare’s latest quarter show?

The quarter ended March 31, 2026 was extraordinary rather than representative. AMN reported $1.378 billion of revenue, double the prior-year quarter, because multiple major labor disruptions generated $722.0 million. The Q1 2026 earnings release also showed gross profit of $368.8 million, net income of $62.2 million, diluted EPS of $1.59 and adjusted EBITDA of $166.1 million.

$1.378B
Q1 2026 revenue
Up 100% year over year and 84% sequentially.
26.8%
Q1 2026 gross margin
Down 190 basis points year over year.
$117.2M
Q1 2026 operating income
Equivalent to an 8.5% operating margin.
$562.5M
Q1 2026 operating cash flow
Boosted by labor-event working-capital timing.
Revenue comparison across reported quarters
$689.5MQ1 2025
$748.2MQ4 2025
$1.378BQ1 2026
The spike is principally event-driven, so the next quarter’s normalized revenue is more informative for recurring earning power.

How much of the quarter came from labor disruption?

52.4%
Labor disruption contributed $722.0M, approximately 52.4% of Q1 2026 consolidated revenue. The arc shows the event-driven share; the track is all other revenue.
Q1 2026 metric Reported result Interpretation
Nurse and Allied revenue $1.127B Up 173% year over year, dominated by disruption work.
Physician and Leadership revenue $163.9M Down 6% year over year; locum-tenens days filled remained pressured.
Technology and Workforce revenue $87.1M Down 15% year over year, including weaker language and VMS revenue.
Cash and cash equivalents $560.7M Temporarily elevated by $367M of client deposits to be settled later.
Debt and leverage $750.0M; 1.6x No revolver draw and lower covenant leverage after the cash surge.

How financially strong is AMN Healthcare after the staffing downcycle?

FY2025 provides the cleanest baseline before the Q1 event spike. Revenue declined 8% to $2.730 billion, gross profit fell 16% to $774.1 million and gross margin compressed to 28.3%. AMN recorded a $95.7 million net loss, reflecting operating pressure and $127.8 million of combined goodwill and long-lived-asset impairments. Operating cash flow was still positive at $269.5 million, while capital expenditures were $35.6 million, implying approximately $233.9 million of simple operating cash flow less capital expenditure.

FY2025 operating baseline
$2.730B revenue
Organic revenue declined across all three segments.
Q1 2026 liquidity snapshot
$560.7M cash
Cash was temporarily lifted by labor-event deposits.

What does the balance sheet allow AMN to do?

At March 31, 2026, AMN had $750 million of senior notes outstanding: $350 million of 4.0% notes due 2029 and $400 million of 6.5% notes due 2031. Its $450 million secured revolver was undrawn, with $429.8 million available after letters of credit. The Q1 2026 Form 10-Q therefore shows meaningful liquidity, but the debt load still makes cash-flow normalization and acquisition discipline important.

LiquidityStrong
Recurring margin visibilityLimited
Debt flexibilityModerate
Technology reinvestment capacityModerate
Acquisition accounting qualityWatch
Cash conversionVariable
Financial item FY2025 Q1 2026 Analytical read
Revenue $2.730B $1.378B Annual contraction was followed by a non-recurring event surge.
Gross margin 28.3% 26.8% Mix and pricing remain central to normalized profitability.
Operating cash flow $269.5M $562.5M Quarterly cash flow includes deposit timing and should not be annualized.
Capital expenditure $35.6M $7.0M Technology investment is meaningful but not highly asset intensive.
Debt outstanding $775.0M $750.0M Debt refinancing extended maturities but increased the cost on new 2031 notes.

What gives AMN Healthcare a competitive advantage?

AMN’s strongest advantage is breadth combined with execution capacity. It can supply multiple clinical disciplines, run MSP and VMS programs, support physician and executive searches, provide language interpretation and mobilize thousands of professionals during a labor event. Smaller agencies may compete effectively in one local niche, but they generally cannot reproduce that integrated national operating stack.

AMN’s moat is not simply a database of clinicians; it is the ability to coordinate talent, credentialing, technology, logistics and workforce data at health-system scale.

How do data and technology strengthen the staffing network?

AMN Passport had more than 340,000 registered users as of January 2026. ShiftWise Flex automates matching, credentialing and candidate self-service, while WorkWise is intended to unify forecasting, scheduling and vendor management. Event Management System capabilities were expanded in 2025 to coordinate AMN-sourced and third-party clinicians during strikes. In June 2026, AMN’s Brightfield partnership added external rate and market benchmarks to AMN’s proprietary healthcare workforce data.

340K+
AMN Passport users
Registered users as of January 2026.
92%
client satisfaction
Reported for 2025 in the 2026 proxy.
+28
Net Promoter Score points
Improvement reported for 2025.
78%
team engagement
2025 enterprise engagement score.

Who competes with AMN?

The market is fragmented, and the competitive set changes by service line. AMN’s 10-K names Amergis, Aya Healthcare, CHG Healthcare Services, Cross Country Healthcare, HealthTrust Workforce Solutions, Ingenovis Health, Jackson Healthcare, LanguageLine Solutions, Medical Solutions and Proprio. Hospitals also compete by building internal staffing pools and recruitment teams.

Competitive arena Named rivals or substitutes AMN positioning
Nurse and allied staffing Aya, Medical Solutions, Cross Country, Ingenovis, Amergis National scale, MSP penetration, multiple disciplines and labor-event execution.
Locum tenens CHG, Jackson Healthcare and specialty firms Cross-selling to health systems and broader physician/leadership services.
Language services LanguageLine, Proprio Healthcare specialization and integration with broader workforce relationships.
Internal substitutes Health-system float pools and internal travel programs AMN must prove cost transparency, fill speed and technology value.

Who owns AMN stock, and how is the company governed?

AMN has one common share class, so economic ownership and voting power are broadly aligned. The investor base is institutionally concentrated rather than founder-controlled. According to the 2026 proxy statement, BlackRock beneficially owned 5.849 million shares, or 15.1%, Vanguard owned 3.635 million, or 9.4%, and Millennium Management owned 2.006 million, or 5.2%, based on the filing sources cited by AMN. Current directors and executive officers as a group owned 412,072 shares, less than 1%.

Holder or group Shares Stake Source period Why it matters
BlackRock 5,849,475 15.1% Proxy disclosures as of March 3, 2026 Large passive or institutional holders can influence governance engagement.
Vanguard 3,634,998 9.4% Proxy disclosures as of March 3, 2026 Reinforces a dispersed, institutionally owned capital structure.
Millennium Management 2,005,966 5.2% Proxy disclosures as of March 3, 2026 Adds an active trading and hedge-fund presence to the shareholder mix.
Directors and executives 412,072 <1% March 3, 2026 Management influence comes more from compensation design than voting control.

What do governance incentives emphasize?

Cary Grace serves as president and chief executive officer, while Brian Scott is chief financial officer and chief operating officer. The board uses equity-heavy compensation and performance awards linked to adjusted EBITDA and total shareholder return. For 2026, the compensation committee restored revenue as an annual-incentive metric after shareholder feedback. This is a meaningful signal: leadership is being asked to balance earnings quality with top-line recovery rather than optimize one adjusted profit measure alone.

Adjusted EBITDARevenue growthRelative TSRAbsolute TSRClient satisfactionBoard refreshment

How do labor disruptions and workforce shortages shape AMN’s economics?

Healthcare labor shortages create long-run demand, but short-run earnings remain cyclical. When hospital vacancy rates rise, AMN can place more temporary staff and often charge higher bill rates. When hospitals improve retention, create internal travel programs or cut contingent-labor budgets, traveler counts and pricing fall. Labor disruptions amplify this volatility: they can generate enormous revenue and cash movements in a single quarter, yet timing is unpredictable.

Which operating metrics reveal the underlying cycle?

Average travelers on assignment
9,227 in Q1 2026 versus 8,981 in Q1 2025; volume turned positive year over year for the first time since 2022.
Travel nurse bill rates and hours
Rates indicate labor tightness and pay-package pressure; billable hours show actual delivered volume.
Locum-tenens days filled
46,645 in Q1 2026, down from 51,342 in Q1 2025, indicating continued physician-volume pressure.
Revenue per locum day
$2,812 in Q1 2026 versus $2,743 in Q1 2025; pricing partly offset lower days filled.
Language minutes and VMS use
Utilization and pricing determine whether the higher-margin technology segment can stabilize.
MSP revenue share
A higher share deepens client integration but can increase customer concentration and procurement pressure.

The Q2 2026 outlook illustrates the normalization problem. Management guided to $620–$635 million of revenue, 28.0%–28.5% gross margin and 6.7%–7.2% adjusted EBITDA margin. It expected only about $10 million of labor-disruption revenue, compared with $722 million in Q1. A DCF model should therefore avoid extrapolating the Q1 run rate and instead build separate assumptions for recurring staffing, technology services and episodic labor events.

What opportunities and risks could change AMN Healthcare’s outlook?

The most attractive opportunity is to convert staffing scale into a data-rich workforce platform with more recurring, higher-margin revenue. The most important counter-risk is that clients use the same technology, internal pools and procurement leverage to reduce their dependence on external staffing firms.

Opportunity
WorkWise ecosystem
Forecasting, VMS, analytics and market benchmarks can deepen relationships and improve cross-selling.
Pressure point
22% customer concentration
Kaiser’s FY2025 revenue share makes contract economics and service quality especially material.

Where could growth come from?

International nurse placements can benefit when visa availability improves. Physician search and leadership advisory can expand beyond placement into assessment, succession and coaching; AMN’s June 2026 ESSENTIAL Leadership Assessment acquisition added software, methodology and more than 1,000 completed assessments. Technology can also improve recruiter productivity, credentialing speed and clinician engagement, lowering the cost to fill each assignment.

Which risks deserve the most weight?

Risk Financial line affected Concrete monitor
Hospital cost containment and internal staffing Revenue, bill rates and gross margin Traveler volume, orders, fill rate and MSP renewals
Kaiser concentration Revenue and working capital Contract retention, pricing and share of consolidated revenue
Credentialing, clinical and professional liability Insurance expense, reserves and reputation Claims experience, reserve adjustments and client satisfaction
Technology competition and cybersecurity Technology revenue, remediation cost and client retention VMS revenue, language pricing, incidents and platform uptime
Acquisition and goodwill risk Impairment charges and return on invested capital Segment forecasts, WACC assumptions and acquired-business margins
State staffing regulation Compliance cost and pricing flexibility Licensing rules, rate caps and worker-classification changes

Why does AMN Healthcare’s business model matter for valuation?

AMN cannot be valued responsibly by applying one growth rate to reported Q1 2026 revenue. Its earning power depends on the mix between recurring staffing, episodic labor disruption, physician and leadership services, and higher-margin technology-enabled offerings. A valuation model should normalize working capital, separate event revenue and test whether technology investments improve margin rather than merely defend share.

Which DCF drivers should researchers model explicitly?

Normalized revenue base
Start from recurring staffing and technology activity, then model labor disruptions separately.
Segment gross margin
A shift toward technology can lift profit, while clinician pay compression and pricing pressure reduce it.
Working-capital reversal
Q1 2026 deposits inflated cash; future settlement reduces cash without necessarily reducing earnings.
Technology capex and productivity
Model spending against recruiter productivity, fill speed, retention and platform revenue.
Debt and interest
$750M of notes require interest coverage through a staffing cycle.
Acquisition returns
Compare acquired cash flows with purchase price, goodwill and subsequent impairment.

For comparable-company analysis, staffing peers may look similar on revenue but differ sharply in MSP penetration, client concentration, technology mix and debt. For intrinsic valuation, the decisive question is whether AMN can stabilize recurring revenue while retaining enough spread between bill rates and clinician costs to fund technology, interest and selective acquisitions.

What is the key takeaway from AMN Healthcare analysis?

AMN matters because it sits at the intersection of healthcare labor scarcity, hospital cost pressure and workforce technology. Its national clinician network, MSP relationships, credentialing infrastructure and labor-event execution create a scale advantage that smaller staffing agencies struggle to match. Its technology and language businesses offer a path toward higher-margin, more embedded client relationships.

Final synthesis
The central tension is that AMN’s strongest quarterly results can come from unpredictable disruption events, while its durable value depends on recurring staffing demand, technology adoption and disciplined capital allocation. The company entered mid-2026 with substantial liquidity and lower leverage, but FY2025 impairments, customer concentration and softer physician and technology trends show that scale alone does not guarantee attractive returns.

What should students and investors monitor next?

  • Revenue excluding labor-disruption activity and the gap between reported and normalized growth.
  • Nurse and allied traveler counts, fill rates, bill rates and clinician pay-package spreads.
  • Locum-tenens days filled and revenue per day, especially after the FY2025 impairment.
  • Technology and Workforce revenue, gross margin, language pricing and VMS client retention.
  • Settlement of Q1 2026 client deposits and the resulting working-capital cash outflow.
  • Kaiser concentration, contract economics and MSP renewal quality.
  • Debt reduction, interest coverage and returns from new acquisitions or advisory products.
  • Evidence that WorkWise, AMN Passport and workforce intelligence improve retention, fill speed and operating efficiency.

The company’s investor-relations reporting hub provides the next earnings package, filings and governance updates. The analytical discipline is straightforward: treat Q1 2026 as proof of execution capability, not as a recurring run rate, and judge the longer-term story by normalized cash flow, segment margins and client-platform depth.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(AMN) AMN Healthcare Services, Inc. Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5